Exchange: NASDAQ·Updated 07:52 PM EST

TWST Earnings

Latest Earnings Results: Q4 '26

Reported: Nov 12

Estimated EPS

-$0.39

Reported EPS

-$0.32

Surprise

+17.33%

Estimated Rev

$123.55M

Reported Rev

$126.64M

Surprise

+2.51%

• Reported GAAP EPS of -$0.32 up 28.89% YoY • Reported revenue of $126.64M up 27.91% YoY • Twist Bioscience expects Fiscal 2027 revenue of approximately $550M to $560M, gross margin of approximately 52.5% to 53%, and positive adjusted EBITDA; Q1 FY2027 revenue guidance is $130M to $132M.

Generated by Stocktwits using AI and company-reported earnings data for Q4 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Investor Presentation10-K

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q1 '27
-$0.36
--
--
N/A
Q4 '26
-$0.39
-$0.32
17.33%
BEAT
Q3 '26
-$0.49
-$0.56
-13.51%
MISSED
Q2 '26
-$0.48
-$0.71
-48.72%
MISSED
Q1 '26
-$0.42
-$0.50
-17.92%
MISSED

Advertisement|Remove ads.